Health
PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs – Technology Networks
Scientists have shown that PD-L1 is a potential anti-cancer therapy target for the treatment of metastasized oral malignant melanoma in dogs.
Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.
There are a number of cancers that affect dogs, but there are far fewer diagnosis and treatment options for these canine cancers. However, as dogs and humans are both mammals, it is likely that strategies and treatments for cancers in humans can be used for canine cancer, with minor modifications.
A team of scientists, including Associate Professor Satoru…
-
Noosa News23 hours agoBali traveller sparks urgent measles alert across Queensland
-
Noosa News23 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business23 hours agoThe best ASX ETFs for compounding wealth until 2040
-
Noosa News22 hours agoMeasles alert issued south of Brisbane after traveller tests positive